Copy number a major source of variation

Thanks to engrained lessons from cytogenetics, researchers largely regarded variations in gene copy a rarity, synonymous with defects. Increasingly, however, researchers have found that large-scale deletions and duplications are the norm and represent a significant source of human variation.Jonathan Sebat and colleagues based at Cold Spring Harbor Laboratory published a highly cited paper on this topic in 2004,1 as did Charles Lee at Brigham and Women's Hospital in Boston.2

Written byIshani Ganguli
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Thanks to engrained lessons from cytogenetics, researchers largely regarded variations in gene copy a rarity, synonymous with defects. Increasingly, however, researchers have found that large-scale deletions and duplications are the norm and represent a significant source of human variation.

Jonathan Sebat and colleagues based at Cold Spring Harbor Laboratory published a highly cited paper on this topic in 2004,1 as did Charles Lee at Brigham and Women's Hospital in Boston.2

Sebat and his team were running two normal DNA controls for a cancer genome study, and "copy number differences jumped out at us," he says. When they analyzed the high-resolution genomic arrays of 20 people, they found 76 unique copy-number polymorphisms (CNPs) of roughly 465 K, many affecting key functional genes. On average, individuals differed by eleven CNPs. Lee is now databasing such variants, which he says account for a staggering 100 million nucleotides of reference DNA.

Several groups have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies